Vimarsana
Biggest News Aggregation in the World

Page 39 - Trials Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trials Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trials Network Today - Breaking & Trending Today

GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent - Vimarsana News

GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent

Press release content from NewMediaWire. The AP news staff was not involved in its creation. GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent GeoVax, Inc.April 1, 2021 GMT Therapeutic Vaccine Would Address Medical Need of Over 250 Million Worldwide Atlanta, GA - ( NewMediaWire ) - April 01, 2021 - GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Pate...

Source: apnews.com
Antibody Mediated Prevention (AMP) trials data published by the i New England Journal of Medicine /i - Vimarsana News

Antibody Mediated Prevention (AMP) trials data published by the i New England Journal of Medicine /i

Antibody Mediated Prevention (AMP) trials data published by the New England Journal of Medicine Most advanced clinical trials testing broadly neutralizing antibody against HIV demonstrate efficacy against sensitive strains Public Relations Pacific LLC  E-Mail SEATTLE - (EMBARGOED UNTIL MARCH 17, 2021, AT 5 P.M. ET) - The proof-of-concept AMP studies demonstrated that a broadly neutralizing antibody (bnAb) called VRC01 was effective at preventing the acquisition of HIV strains to the 30% of strains that were sensitive to the bnAb. This finding was seen both in Sub-Sahara...

Universal 'test and treat' an economically efficient strategy to help control HIV epidemic in southern Africa - Vimarsana News

Universal 'test and treat' an economically efficient strategy to help control HIV epidemic in southern Africa

Universal ‘test and treat’ an economically efficient strategy to help control HIV epidemic in southern Africa Universal ‘test and treat’ an economically efficient strategy to help control HIV epidemic in southern Africa 13 March 2021 London School of Hygiene & Tropical Medicine London School of Hygiene & Tropical Medicine https://lshtm.ac.uk/themes/custom/lshtm/images/lshtm-logo-black.png Package of HIV prevention methods can be delivered through community health workers at scale for a low-cost Share A package of HIV preventi...

In trial, cabotegravir delayed detection of some incident HIV infections - Vimarsana News

In trial, cabotegravir delayed detection of some incident HIV infections

In trial, cabotegravir delayed detection of some incident HIV infections Source: Landovitz R, et al. Abstract 153LB. Presented at: Conference on Retroviruses and Opportunistic Infections; March 6-10, 2021 (virtual meeting). Disclosures: Landovitz reports serving on scientific advisory boards for Gilead Sciences and Merck and receiving honoraria from Roche. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED T...

Source: healio.com
Research Nurse - Vimarsana News

Research Nurse

Monitoring and Evaluation Job in USA about Health, requiring 3-4 years of experience, from ICAP; closing on 05 Apr 2021